PoliCheck Network
← Back to bills
H.R. 1189119th CongressReferred to the House Committee on Energy and Commerce.

National Plan for Epilepsy Act

Introduced: Feb 11, 2025
Latest action: Feb 11, 2025

Latest Action

Referred to the House Committee on Energy and Commerce.

1
Primary Sponsors
94
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Gregory F. Murphy

Gregory F. Murphy

Republican • North Carolina • District 3

Original Cosponsor

Feb 11, 2025

View profile →

Ted Lieu

Ted Lieu

Democrat • California • District 36

Mar 3, 2025

View profile →

Brian K. Fitzpatrick

Brian K. Fitzpatrick

Republican • Pennsylvania • District 1

Mar 6, 2025

View profile →

Michael Lawler

Michael Lawler

Republican • New York • District 17

Mar 21, 2025

View profile →

Nydia M. Velázquez

Nydia M. Velázquez

Democrat • New York • District 7

Mar 25, 2025

View profile →

Seth Moulton

Seth Moulton

Democrat • Massachusetts • District 6

Mar 31, 2025

View profile →

John R. Moolenaar

John R. Moolenaar

Republican • Michigan • District 2

Apr 17, 2025

View profile →

Gus M. Bilirakis

Gus M. Bilirakis

Republican • Florida • District 12

May 5, 2025

View profile →

Laura Gillen

Laura Gillen

Democrat • New York • District 4

May 5, 2025

View profile →

Eleanor Holmes Norton

Eleanor Holmes Norton

Democrat • District of Columbia

Jun 3, 2025

View profile →

Shri Thanedar

Shri Thanedar

Democrat • Michigan • District 13

Jun 5, 2025

View profile →

Debbie Dingell

Debbie Dingell

Democrat • Michigan • District 6

Jun 5, 2025

View profile →

Steny H. Hoyer

Steny H. Hoyer

Democrat • Maryland • District 5

Jun 20, 2025

View profile →

Steve Cohen

Steve Cohen

Democrat • Tennessee • District 9

Jun 24, 2025

View profile →

Henry Cuellar

Henry Cuellar

Democrat • Texas • District 28

Jun 25, 2025

View profile →

Mike Quigley

Mike Quigley

Democrat • Illinois • District 5

Jul 2, 2025

View profile →

Rashida Tlaib

Rashida Tlaib

Democrat • Michigan • District 12

Jul 10, 2025

View profile →

Sean Casten

Sean Casten

Democrat • Illinois • District 6

Jul 17, 2025

View profile →

Greg Landsman

Greg Landsman

Democrat • Ohio • District 1

Jul 22, 2025

View profile →

Eric Sorensen

Eric Sorensen

Democrat • Illinois • District 17

Jul 29, 2025

View profile →

Darin LaHood

Darin LaHood

Republican • Illinois • District 16

Aug 1, 2025

View profile →

Morgan McGarvey

Morgan McGarvey

Democrat • Kentucky • District 3

Sep 2, 2025

View profile →

Lois Frankel

Lois Frankel

Democrat • Florida • District 22

Sep 2, 2025

View profile →

Jennifer A. Kiggans

Jennifer A. Kiggans

Republican • Virginia • District 2

Sep 10, 2025

View profile →

Janelle S. Bynum

Janelle S. Bynum

Democrat • Oregon • District 5

Sep 15, 2025

View profile →

Sharice Davids

Sharice Davids

Democrat • Kansas • District 3

Sep 30, 2025

View profile →

Diana Harshbarger

Diana Harshbarger

Republican • Tennessee • District 1

Sep 30, 2025

View profile →

Josh Gottheimer

Josh Gottheimer

Democrat • New Jersey • District 5

Oct 10, 2025

View profile →

Sarah McBride

Sarah McBride

Democrat • Delaware

Oct 10, 2025

View profile →

Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican • Georgia • District 1

Oct 21, 2025

View profile →

Thomas H. Kean

Thomas H. Kean

Republican • New Jersey • District 7

Oct 24, 2025

View profile →

April McClain Delaney

April McClain Delaney

Democrat • Maryland • District 6

Oct 28, 2025

View profile →

Jamie Raskin

Jamie Raskin

Democrat • Maryland • District 8

Nov 10, 2025

View profile →

Mark Pocan

Mark Pocan

Democrat • Wisconsin • District 2

Nov 10, 2025

View profile →

Lateefah Simon

Lateefah Simon

Democrat • California • District 12

Nov 10, 2025

View profile →

Paul Tonko

Paul Tonko

Democrat • New York • District 20

Nov 17, 2025

View profile →

Scott H. Peters

Scott H. Peters

Democrat • California • District 50

Nov 19, 2025

View profile →

Doris O. Matsui

Doris O. Matsui

Democrat • California • District 7

Nov 19, 2025

View profile →

Lori Trahan

Lori Trahan

Democrat • Massachusetts • District 3

Nov 19, 2025

View profile →

Darren Soto

Darren Soto

Democrat • Florida • District 9

Nov 20, 2025

View profile →

Timothy M. Kennedy

Timothy M. Kennedy

Democrat • New York • District 26

Dec 1, 2025

View profile →

Glenn Ivey

Glenn Ivey

Democrat • Maryland • District 4

Dec 11, 2025

View profile →

Hillary J. Scholten

Hillary J. Scholten

Democrat • Michigan • District 3

Dec 15, 2025

View profile →

James C. Moylan

James C. Moylan

Republican • Guam

Dec 17, 2025

View profile →

Danny K. Davis

Danny K. Davis

Democrat • Illinois • District 7

Dec 17, 2025

View profile →

André Carson

André Carson

Democrat • Indiana • District 7

Dec 30, 2025

View profile →

Eugene Simon Vindman

Eugene Simon Vindman

Democrat • Virginia • District 7

Jan 12, 2026

View profile →

Julia Letlow

Julia Letlow

Republican • Louisiana • District 5

Jan 12, 2026

View profile →

Ryan Mackenzie

Ryan Mackenzie

Republican • Pennsylvania • District 7

Jan 15, 2026

View profile →

Eric Swalwell

Eric Swalwell

Democrat • California • District 14

Jan 20, 2026

View profile →

Julia Brownley

Julia Brownley

Democrat • California • District 26

Jan 21, 2026

View profile →

Christopher R. Deluzio

Christopher R. Deluzio

Democrat • Pennsylvania • District 17

Jan 30, 2026

View profile →

Kimberlyn King-Hinds

Kimberlyn King-Hinds

Republican • Northern Mariana Islands

Jan 30, 2026

View profile →

Adelita S. Grijalva

Adelita S. Grijalva

Democrat • Arizona • District 7

Feb 3, 2026

View profile →

Maria Elvira Salazar

Maria Elvira Salazar

Republican • Florida • District 27

Feb 17, 2026

View profile →

David G. Valadao

David G. Valadao

Republican • California • District 22

Feb 20, 2026

View profile →

Carol D. Miller

Carol D. Miller

Republican • West Virginia • District 1

Feb 23, 2026

View profile →

James R. Walkinshaw

James R. Walkinshaw

Democrat • Virginia • District 11

Feb 25, 2026

View profile →

Ro Khanna

Ro Khanna

Democrat • California • District 17

Mar 3, 2026

View profile →

Haley M. Stevens

Haley M. Stevens

Democrat • Michigan • District 11

Mar 3, 2026

View profile →

Donald Norcross

Donald Norcross

Democrat • New Jersey • District 1

Mar 5, 2026

View profile →

Robin L. Kelly

Robin L. Kelly

Democrat • Illinois • District 2

Mar 16, 2026

View profile →

Deborah K. Ross

Deborah K. Ross

Democrat • North Carolina • District 2

Mar 26, 2026

View profile →

John Joyce

John Joyce

Republican • Pennsylvania • District 13

Apr 9, 2026

View profile →

Jake Auchincloss

Jake Auchincloss

Democrat • Massachusetts • District 4

Apr 9, 2026

View profile →

Janice D. Schakowsky

Janice D. Schakowsky

Democrat • Illinois • District 9

Apr 9, 2026

View profile →

Suhas Subramanyam

Suhas Subramanyam

Democrat • Virginia • District 10

Apr 20, 2026

View profile →

Bill Huizenga

Bill Huizenga

Republican • Michigan • District 4

Apr 20, 2026

View profile →

Greg Stanton

Greg Stanton

Democrat • Arizona • District 4

Apr 22, 2026

View profile →

Lucy McBath

Lucy McBath

Democrat • Georgia • District 6

Apr 27, 2026

View profile →

Jack Bergman

Jack Bergman

Republican • Michigan • District 1

May 11, 2026

View profile →

Michael R. Turner

Michael R. Turner

Republican • Ohio • District 10

May 11, 2026

View profile →

Valerie P. Foushee

Valerie P. Foushee

Democrat • North Carolina • District 4

May 11, 2026

View profile →

Ilhan Omar

Ilhan Omar

Democrat • Minnesota • District 5

May 13, 2026

View profile →

Don Bacon

Don Bacon

Republican • Nebraska • District 2

May 29, 2026

View profile →

Becca Balint

Becca Balint

Democrat • Vermont

May 29, 2026

View profile →

Josh Harder

Josh Harder

Democrat • California • District 9

May 29, 2026

View profile →

Nick LaLota

Nick LaLota

Republican • New York • District 1

Jun 4, 2026

View profile →

Suzan K. DelBene

Suzan K. DelBene

Democrat • Washington • District 1

Jun 18, 2026

View profile →

Steven Horsford

Steven Horsford

Democrat • Nevada • District 4

Jun 23, 2026

View profile →

Claudia Tenney

Claudia Tenney

Republican • New York • District 24

Jun 24, 2026

View profile →

Thomas R. Suozzi

Thomas R. Suozzi

Democrat • New York • District 3

Jun 30, 2026

View profile →

Yvette D. Clarke

Yvette D. Clarke

Democrat • New York • District 9

Jul 9, 2026

View profile →

Nellie Pou

Nellie Pou

Democrat • New Jersey • District 9

Jul 13, 2026

View profile →

Kathy Castor

Kathy Castor

Democrat • Florida • District 14

Jul 14, 2026

View profile →

Shontel M. Brown

Shontel M. Brown

Democrat • Ohio • District 11

Jul 15, 2026

View profile →

Shomari Figures

Shomari Figures

Democrat • Alabama • District 2

Jul 15, 2026

View profile →

Gabe Amo

Gabe Amo

Democrat • Rhode Island • District 1

Jul 21, 2026

View profile →

Kevin Mullin

Kevin Mullin

Democrat • California • District 15

Aug 10, 2026

View profile →

Zachary Nunn

Zachary Nunn

Republican • Iowa • District 3

Aug 10, 2026

View profile →

Kim Schrier

Kim Schrier

Democrat • Washington • District 8

Aug 10, 2026

View profile →

Nikema Williams

Nikema Williams

Democrat • Georgia • District 5

Aug 31, 2026

View profile →

Donald G. Davis

Donald G. Davis

Democrat • North Carolina • District 1

Aug 31, 2026

View profile →

LaMonica McIver

LaMonica McIver

Democrat • New Jersey • District 10

Aug 31, 2026

View profile →

Recorded Actions

Official legislative actions recorded for this measure.

H11100Feb 11, 2025

Referred to the House Committee on Energy and Commerce.

Official source ↗
Intro-HFeb 11, 2025

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 1189. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

NATIONAL ASSOCIATION OF EPILEPSY CENTERS

Registrant: ARTEMIS POLICY GROUP LLC

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Medicare/Medicaid: Reimbursement for healthcare services provided by epilepsy centers Health Issues: HR 1189/S 494 National Plan for Epilepsy Act

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF EPILEPSY CENTERS

Registrant: ARTEMIS POLICY GROUP LLC

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Medicare/Medicaid: Reimbursement for healthcare services provided by epilepsy centers Health Issues: HR 1189/S 494 National Plan for Epilepsy Act

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF EPILEPSY CENTERS

Registrant: ARTEMIS POLICY GROUP LLC

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Medicare/Medicaid: Reimbursement for healthcare services provided by epilepsy centers HR 1, One Big Beautiful Bill Act Letter to House and Senate Leaders requesting extension of expiring Telehealth services under Medicare Insurance: HR 1, One Big Beautiful Bill Act Health Issues: HR 1189/S 494 National Plan for Epilepsy Act

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF EPILEPSY CENTERS

Registrant: ARTEMIS POLICY GROUP LLC

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Medicare/Medicaid: Reimbursement for healthcare services provided by epilepsy centers HR 1, One Big Beautiful Bill Act Letter to House and Senate Leaders requesting extension of expiring Telehealth services under Medicare Comments RE: Proposed Rule on Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Proposed Rule (CMS-1834-P) Comments RE: Proposed Rule on Medicare and Medicaid Programs; CY 2026 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program (CMS-1832-P) Insurance: HR 1, One Big Beautiful Bill Act Health Issues: HR 1189/S 494 National Plan for Epilepsy Act Budget/Appropriations: Letter to House and Senate Appropriations Committee leaders on funding for epilepsy programs in Departments of Labor HHS, Department of Defense and Military Construction and Veterans Affairs FY 26 Appropriations Bills

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF EPILEPSY CENTERS

Registrant: ARTEMIS POLICY GROUP LLC

2nd Quarter (Apr 1 - June 30)
Jul 18, 2025

Reported lobbying issue

Medicare/Medicaid: Reimbursement for healthcare services provided by epilepsy centers Telehealth services HR 1, One Big Beautiful Bill Act Insurance: HR 1, One Big Beautiful Bill Act Health Issues: HR 1189/S 494 National Plan for Epilepsy Act Budget/Appropriations: Funding for NIH and reorganization plans CDC Epilepsy Program FY26 House and Senate Labor-HHS Appropriations bills

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2027, support funding for epilepsy programs and research including $11.581 billion for the CDC including $11.5 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program; language supporting a report about establishing a National Plan for Epilepsy; at least $51.3 billion for the NIH and $468 million for the BRAIN Initiative; increased funding for the Social Security Administration; and language supporting a report about how the newborn screening evidence-based review process will continue to be implemented and language clarifying that Title V can fund state-sponsored genetic screening pilot programs. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2027, support at least $29 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2027, support robust funding for the Food & Drug Administration -Defense Appropriations Act, 2027, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $12 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. Health Issues: -P.L. 119-21, Support policies and processes that reduce the impact of the cuts and changes to Medicaid on people with serious and chronic conditions, people with disabilities, and caregivers -Budget Reconciliation Packages, oppose additional cuts to Medicaid -S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage -Requests to join the Congressional Epilepsy Caucus -S. 2903/H.R. 5509, Safe Step Act, support passage -S. 864/H.R. 6423, HELP Copays Act, support passage -WISeR Model, express concern with how it could impede access to some epilepsy treatments -PBM Reform, support legislative and regulatory policies on PBM reform and the inclusion of patient-centric policies -Medicare Part Ds Six Protected Classes policy, support coverage of and access to all epilepsy treatments and express concerns with the impact of the GUARD Model on the Six Protected Classes policy. -ACA marketplace rule, express concerns that changes will decrease enrollment and increase costs -Telehealth, support extensions of telehealth flexibilities including the prescribing of epilepsy medications that are controlled substances -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -U.S. Department of Health and Human Services (HHS), support protecting the current structure of HHS and express concerns with HHS staffing changes and cuts -NIH, support the current structure, current facilities and administrative cost structure, and grantmaking process of the NIH; express concerns with leadership and staffing changes and an expansion of multiyear funding -Support programs that assist caregivers -Oppose legislative or regulatory policies that rely on metrics like Quality-Adjusted Life Years -Support rescheduling and safe and legal access to medical cannabis -S. 1816/ H.R. 3514, Improving Seniors Timely Access to Care Act, support passage -Express concerns with legislative and regulatory policies that would restrict the use of animals in research -Support legislation and policy preserving charitable giving including the Combined Federal Campaign -H.R. 6280, Access to Genetic Counselor Services Act, support passage -S. 4440, Clinical Trial Modernization Act, support passage -Support legislation and regulations that protect Medicaid Home- and Community-Based Services (HCBS) and increase access to these services -Prescription Drug User Fee Act Reauthorization, support priorities for the rare disease community -Fiscal Year 2027 Hospital Inpatient Prospective Payment Systems Proposed Rule, oppose proposals to repeal the alternative pathway for new technology add-on payments for breakthrough devices and eliminate the hospital outpatient prospective payment system device pass-through payments Civil Rights/Civil Liberties: -FAA reauthorization, support implementation of disability provisions -Surface Transportation Reauthorization, support inclusion of disability and accessibility provisions -Autonomous vehicle legislation, support the inclusion of disability and accessibility provisions -Supported temporary exemptions to NHTSA safety requirements to test autonomous vehicles Education: -Department of Education, oppose Reductions of Force at and changes to (including moving sections of) the Dept. of Education that could impede the rights of students with disabilities -S. 3448/H.R. 6617, Keeping All Students Safe Act, support passage

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA) Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) Natl Institutes of Health (NIH) Veterans Affairs, Dept of (VA) Federal Aviation Administration (FAA) Transportation, Dept of (DOT) Education, Dept of

Reported filing-period amount: $150,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

UCB, INC.

Registrant: UCB, INC.

2nd Quarter (Apr 1 - June 30)
Jul 17, 2026

Reported lobbying issue

Pharmacy: H.R. 5509/S. 2903 - Safe Step Act H.R. 6423/S. 864 - HELP Copays Act H.R. 1189/S. 494 - National Plan for Epilepsy Act Drug Pricing Trade (domestic/foreign): Tariffs

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Commerce, Dept of (DOC) U.S. Trade Representative (USTR)

Reported filing-period amount: $710,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

LUNDBECK LLC

Registrant: LUNDBECK LLC

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Health Issues: Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act Medicare/Medicaid: Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Issues pertaining to prior authorization - HR 3514, Improving Seniors Timely Access to Care Act Trade (domestic/foreign): Tariffs on pharmaceutical products

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $180,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Education: -Department of Education, oppose Reductions of Force at and changes to (including moving sections of) the Dept. of Education that could impede the rights of students with disabilities -S. 3448/H.R. 6617, Keeping All Students Safe Act, support passage Budget/Appropriations: -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2026, support funding for epilepsy programs and research including $11.581 billion for the CDC including $11.5 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program, at least $48.7 billion for the NIH, $680 million for the BRAIN Initiative, and increased funding for the Social Security Administration. -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2027, support funding for epilepsy programs and research including $11.581 billion for the CDC including $11.5 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program; language supporting a report about establishing a National Plan for Epilepsy; at least $51.303 billion for the NIH and $468 million for the BRAIN Initiative; increased funding for the Social Security Administration; and language supporting a report about how the newborn screening evidence-based review process will continue to be implemented and language clarifying that Title V can fund state-sponsored genetic screening pilot programs. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2027, support at least $29 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2027, support robust funding for the Food & Drug Administration -Defense Appropriations Act, 2026, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $10 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. -Defense Appropriations Act, 2027, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $12 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. -Commerce, Justice, Science Appropriations Act, 2026, oppose provisions that could restrict access to CBD and block rescheduling Health Issues: -P.L. 119-21, Support policies and processes that reduce the impact of the cuts and changes to Medicaid on people with serious and chronic conditions, people with disabilities, and caregivers -S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage -Requests to join the Congressional Epilepsy Caucus -S. 2903/H.R. 5509, Safe Step Act, support passage -S. 864/H.R. 6423, HELP Copays Act, support passage -S. 932/ H.R. 1262, Give Kids A Chance Act, support reauthorization of the Rare Pediatric Disease Review Voucher -WISeR Model, express concern with how it could impede access to some epilepsy treatments -PBM Reform, support passage and the inclusion of patient-centric policies -Medicare Part Ds Six Protected Classes policy, support coverage of and access to all epilepsy treatments and express concerns with the impact of the GUARD Model on the Six Protected Classes policy. -Enhanced Advance Premium Tax Credits, support reauthorization. -Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan, support patient-centric implementation -ACA marketplace rule, express concerns that changes will decrease enrollment and increase costs -Telehealth, support extensions of telehealth flexibilities including the prescribing of epilepsy medications that are controlled substances -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -S. 752/H.R. 1509, Accelerating Kids Access to Care Act, support passage -U.S. Department of Health and Human Services (HHS), support protecting the current structure of HHS and express concerns with HHS staffing changes and cuts -NIH, support the current structure, current facilities and administrative cost structure, and grantmaking process of the NIH; express concerns with leadership and staffing changes and an expansion of multiyear funding -Support programs that assist caregivers -Oppose legislative or regulatory policies that rely on metrics like Quality-Adjusted Life Years -Support rescheduling and safe and legal access to medical cannabis -S. 1816/ H.R. 3514, Improving Seniors Timely Access to Care Act, support passage -S. 455/H.R. 1061, Protecting Sensitive Locations Act, support passage -Oppose legislation that would weaken the Affordable Care Act protections, including H.R. 2528, Association Health Plans Act and H.R. 2571, Self-Insurance Protection Act -Express concerns with legislative and regulatory policies that would restrict the use of animals in research -Support legislation and policy preserving charitable giving including the Combined Federal Campaign -H.R. 6280, Access to Genetic Counselor Services Act, support passage -Support legislation and regulations that protect Medicaid Home- and Community-Based Services (HCBS) and increase access to these services Civil Rights/Civil Liberties: -FAA reauthorization, support implementation of disability provisions -Surface Transportation Reauthorization, support inclusion of disability and accessibility provisions -Autonomous vehicle legislation, support the inclusion of disability and accessibility provisions

Government entities reported: Education, Dept of HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Natl Institutes of Health (NIH) Veterans Affairs, Dept of (VA) Federal Aviation Administration (FAA) Transportation, Dept of (DOT)

Reported filing-period amount: $80,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VALLEY CHILDREN'S HEALTHCARE

Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31)
Apr 17, 2026

Reported lobbying issue

Health Issues: Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

LUNDBECK LLC

Registrant: LUNDBECK LLC

1st Quarter (Jan 1 - Mar 31)
Apr 16, 2026

Reported lobbying issue

Health Issues: Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Medicare/Medicaid: Issues pertaining to the 340B Drug Discount Program - H.R. 5256, 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to Pharmacy Benefit Managers - S.3345, PBM Price Transparency and Accountability Act; H.R.4317, PBM Reform Act of 2025 Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Trade (domestic/foreign): Tariffs on pharmaceutical products

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $130,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

LUNDBECK LLC

Registrant: LUNDBECK LLC

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Health Issues: Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Appropriations BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Medicare/Medicaid: Issues pertaining to the 340B Drug Discount Program - H.R. 5256, 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers - S.3345, PBM Price Transparency and Accountability Act; H.R.4317, PBM Reform Act of 2025 Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy Issues pertaining to migraine screening for women in Medicare - FY 2026 Labor-HHS Appropriations Trade (domestic/foreign): Tariffs on pharmaceutical products

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $170,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Budget/Appropriations: -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2026, support funding for epilepsy programs and research including $11.581 billion for the CDC including $11.5 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program, at least $48.7 billion for the NIH, $680 million for the BRAIN Initiative, and increased funding for the Social Security Administration. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, support at least $29.212 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2026, support robust funding for the Food & Drug Administration; oppose provisions that could restrict access to CBD and block rescheduling of cannabis -Defense Appropriations Act, 2026, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $10 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. -Commerce, Justice, Science Appropriations Act, 2026, oppose provisions that could restrict access to CBD and block rescheduling Health Issues: -H.R. 1, Oppose cuts and changes to Medicaid and support policies and processes that reduce the impact of these cuts and changes on people with serious and chronic conditions, people with disabilities, and caregivers -S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage -Requests to join the Congressional Epilepsy Caucus -S. 2903/H.R. 5509, Safe Step Act, support passage -S. 864/H.R. 6423, HELP Copays Act, support passage -S. 932/ H.R. 1262, Give Kids A Chance Act, support reauthorization of the Rare Pediatric Disease Review Voucher -Express concern with the WISeR Model and how it could impede access to some epilepsy treatments -PBM Reform, support patient-centric policies including inclusion of the Safe Step Act and HELP Copays Act -Support coverage of and access to all epilepsy treatments including through preservation of Medicare Part Ds Six Protected Classes policy. Express concerns with the impact of the GUARD Model on the Six Protected Classes policy. -Support reauthorization of the enhanced Advance Premium Tax Credits -Support patient-centric implementation of Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan -ACA marketplace rule, express concerns that changes will decrease enrollment and increase costs -Ensure continued access to needed healthcare via telehealth including at the VA and prescribing of epilepsy medications that are controlled substances -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -S. 752/H.R. 1509, Accelerating Kids Access to Care Act, support passage -Support protecting the current structure of the U.S. Department of Health and Human Services (HHS) -Support the facilities and administrative cost structure for the NIH -Express support for the current grantmaking process of the NIH, including opposing an expansion of multiyear funding -Express concerns with HHS staffing changes and cuts -Support programs that assist caregivers -Oppose legislative or regulatory policies that rely on metrics like Quality-Adjusted Life Years -Support rescheduling and safe and legal access to cannabis -S. 1816/ H.R. 3514, Improving Seniors Timely Access to Care Act, support passage -S. 455/H.R. 1061, Protecting Sensitive Locations Act, support passage -Oppose legislation that would weaken the Affordable Care Act protections, including H.R. 2528, Association Health Plans Act and H.R. 2571, Self-Insurance Protection Act -Express concerns with legislative and regulatory policies that would restrict the use of animals in research -Support legislation and policy preserving charitable giving including the Combined Federal Campaign -H.R. 6280, Access to Genetic Counselor Services Act, support passage -Oppose the Consumer Financial Protection Bureau rule stating that the Fair Credit Reporting Act (FCRA) preempts state laws on credit reporting -Express concerns with the proposed public charge regulation and its impacts on coverage and access to care for people with chronic conditions and disabilities, including immigrants and their lawful permanent resident or U.S. citizen family members -Support legislation and regulations that protect Medicaid Home- and Community-Based Services (HCBS) and increase access to these services Civil Rights/Civil Liberties: -Support implementation of disability provisions in FAA reauthorization -Oppose the order to end funding for youth LGBTQ+ services on the 988 hotline -Oppose final rules on non-discrimination in public programs -Support inclusion of disability/accessibility provisions in Surface Transportation Reauthorization -Support the inclusion of disability and accessibility provisions as part of any autonomous vehicle legislation Education: -Oppose changes to and Reductions of Force at the Department of Education that could impede the rights of students with disabilities -S. 3448/H.R. 6617, Keeping All Students Safe Act, support passage

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Consumer Financial Protection Bureau (CFPB) Health & Human Services, Dept of (HHS) Natl Institutes of Health (NIH) Veterans Affairs, Dept of (VA) Energy, Dept of Federal Aviation Administration (FAA) Transportation, Dept of (DOT) Education, Dept of

Reported filing-period amount: $70,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VALLEY CHILDREN'S HEALTHCARE

Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP

4th Quarter (Oct 1 - Dec 31)
Jan 16, 2026

Reported lobbying issue

Health Issues: Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

LUNDBECK LLC

Registrant: LUNDBECK LLC

3rd Quarter (July 1 - Sep 30)
Oct 28, 2025

Reported lobbying issue

Trade (domestic/foreign): Tariffs on pharmaceutical products Health Issues: Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Give Kids a Chance Act of 2025 H.R. 1262, S. 932 The HEADACHE Act of 2025 - H.R. 5536 National Plan for Epilepsy Act -- H.R. 1189, S. 494 Medicare/Medicaid: Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862 - The ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832 - The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy Issues pertaining to migraine screening for women in Medicare - FY 2026 Labor-HHS Appropriations

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $140,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

LUNDBECK LLC

Registrant: LUNDBECK LLC

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Health Issues: Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Give Kids a Chance Act of 2025 H.R. 1262, S. 932 The HEADACHE Act of 2025 - H.R. 5536 National Plan for Epilepsy Act -- H.R. 1189, S. 494 Medicare/Medicaid: Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 - The ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832 - The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy Issues pertaining to migraine screening for women in Medicare - FY 2026 Labor-HHS Appropriations Trade (domestic/foreign): Tariffs on pharmaceutical products

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $140,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

3rd Quarter (July 1 - Sep 30)
Oct 20, 2025

Reported lobbying issue

Budget/Appropriations: -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2026, support funding for epilepsy programs and research including $11.581 billion for the CDC including $12 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program, $51.3 billion for the NIH, $680 million for the BRAIN Initiative, and increased funding for the Social Security Administration. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, support at least $29.212 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2026, support robust funding for the Food & Drug Administration; oppose provisions that could restrict access to CBD and block rescheduling of cannabis -Defense Appropriations Act, 2026, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $10 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. -Commerce, Justice, Science Appropriations Act, 2026, oppose provisions that could restrict access to cannabis and block rescheduling Health Issues: -H.R. 1, Oppose cuts and changes to Medicaid and support policies and processes that reduce the impact of these cuts and changes on patients, people with disabilities, and caregivers; Oppose cuts to the Affordable Care Act. -S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage. -Requests to join the Congressional Epilepsy Caucus. -S. 2903/H.R. 5509, Safe Step Act, support passage -S. 864, HELP Copays Act, support passage. -S. 932/ H.R. 1262, Give Kids A Chance Act, support reauthorization of the Rare Pediatric Disease Review Voucher -Express concern with the WISeR Model and how it could impede access to some epilepsy treatments -PBM Reform, support patient-centric policies including inclusion of the Safe Step Act and HELP Copays Act -Support coverage of and access to all epilepsy treatments including through preservation of Medicare Part Ds Six Protected Classes policy -Support reauthorization of the enhanced Advance Premium Tax Credits -Support patient-centric implementation of Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan -ACA marketplace rule, express concerns that proposed changes will decrease enrollment and increase costs -Ensure continued access to needed healthcare via telehealth including at the VA and prescribing of epilepsy medications that are controlled substances -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -S. 752/H.R. 1509, Accelerating Kids Access to Care Act, support passage -Support protecting the current structure of the U.S. Department of Health and Human Services (HHS) -Support the FAIR model as an alternative to the facilities and administrative cost structure for the NIH -Express concerns with HHS Reductions in Force related to epilepsy -Support programs that assist caregivers -Oppose legislative or regulatory policies that rely on metrics like Quality-Adjusted Life Years -Support rescheduling and safe and legal access to cannabis -S. 1816/ H.R. 3514, Improving Seniors Timely Access to Care Act, support passage -S. 1717/H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act, support passage -S. 455/H.R. 1061, Protecting Sensitive Locations Act, support passage -Oppose legislation that would weaken the Affordable Care Act protections, including H.R. 2528, Association Health Plans Act and H.R. 2571, Self-Insurance Protection Act -Express concerns with legislative and regulatory policies that would restrict the use of animals in research -Support legislation and policy preserving charitable giving including the Combined Federal Campaign -Oppose proposals to add Durable Medical Equipment Prosthetics, Orthotics, and Supplies to the Competitive Bidding Program -Access to Genetic Counselor Services Act, support passage Civil Rights/Civil Liberties: -Support implementation of disability provisions in FAA reauthorization -Oppose the order to end funding for youth LGBTQ+ services on the 988 hotline -Oppose final rules on non-discrimination in public programs Education: -Oppose changes to and Reductions of Force at the Department of Education that could impede the rights of students with disabilities

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Natl Institutes of Health (NIH) Veterans Affairs, Dept of (VA) Energy, Dept of Federal Aviation Administration (FAA) Transportation, Dept of (DOT) Education, Dept of

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VALLEY CHILDREN'S HEALTHCARE

Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP

3rd Quarter (July 1 - Sep 30)
Oct 16, 2025

Reported lobbying issue

Health Issues: Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

2nd Quarter (Apr 1 - June 30)
Jul 21, 2025

Reported lobbying issue

Budget/Appropriations: -Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2026, support funding for epilepsy programs and research including $11.581 billion for the CDC including $12 million for the CDCs Epilepsy program and $164 million for the CDCs Safe Motherhood and Infant Health Program, $51.3 billion for the NIH, $680 million for the BRAIN Initiative, and increased funding for the Social Security Administration. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, support at least $29.212 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2026, support robust funding for the Food & Drug Administration. -Defense Appropriations Act, 2026, within the Congressionally Directed Medical Research Programs, support $12 million for the Epilepsy Program, $10 million for the Tuberous Sclerosis Complex program and $175 million for the TBI and Psychological Health Program. Health Issues: -H.R. 1, Oppose cuts and changes to Medicaid including instituting work/community engagement requirements, more frequent eligibility checks, higher cost sharing for beneficiaries and restrictions on provider taxes; Oppose cuts to the Affordable Care Act; Support inclusion of the Accelerating Kids Access to Care Act and PBM reform -S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage. -S. 864, HELP Copays Act, support passage. -Support coverage of and access to all epilepsy treatments including through preservation of Medicare Part Ds Six Protected Classes policy -Support reauthorization of the Advance Premium Tax Credits -Support patient-centric implementation of Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan -ACA marketplace rule, express concerns that proposed changes will decrease enrollment and increase costs -Ensure continued access to needed healthcare via telehealth including at the VA and prescribing of epilepsy medications that are controlled substances -Requests to join the Congressional Epilepsy Caucus. -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -Support protecting the current structure of the U.S. Department of Health and Human Services (HHS) -Opposing changes to the Facilities & Administrative Cost Reimbursements at the National Institutes of Health -Support legislation and regulations to reduce the burden of medical debt -Express concerns with HHS Reductions in Force related to epilepsy -Safe Step Act, support passage -Support programs that assist caregivers -Oppose legislative or regulatory policies that rely on metrics like Quality-Adjusted Life Years -Support rescheduling and safe and legal access to cannabis -H.R. 3514/S. 1816, Improving Seniors Timely Access to Care Act, support passage -Oppose legislation that would weaken the Affordable Care Act protections, including H.R. 2528, Association Health Plans Act and H.R. 2571, Self-Insurance Protection Act -Oppose reclassifying scientific positions in federal agencies into Schedule F -Express concerns with proposed changes to the assignment of RNS neurostimulators into Medicare Severity Diagnosis-Related Groups -Express concerns with legislative and regulatory policies that would restrict the use of animals in research -Oppose legislative and regulatory policies targeting non-profits, and support legislation encouraging charitable giving Civil Rights/Civil Liberties: -Support implementation of disability provisions in FAA reauthorization -Oppose the order to end funding for youth LGBTQ+ services on the 988 hotline -Oppose final rules on non-discrimination in public programs Education: -Oppose changes to the Department of Education that could impede the rights of students with disabilities

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Natl Institutes of Health (NIH) Veterans Affairs, Dept of (VA) Energy, Dept of Federal Aviation Administration (FAA) Transportation, Dept of (DOT) Education, Dept of

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION

Registrant: EPILEPSY FOUNDATION

1st Quarter (Jan 1 - Mar 31)
Apr 18, 2025

Reported lobbying issue

Budget/Appropriations: -H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, support funding for epilepsy programs and research including $12.5 Million for the CDC Epilepsy Program; $48.9 Billion for the National Institutes of Health; $680.4 Million for the BRAIN Initiative; $26.8 Million for the VA Epilepsy Centers of Excellence; and within the Congressionally Directed Medical Research Programs: $12 Million for the Epilepsy Research Program, $8 Million for the Tuberous Sclerosis Complex Program, and $175 Million for the TBI and Psychological Health Program. Health Issues: S. 494/H.R. 1189, National Plan for Epilepsy Act, support passage. -S. 864, HELP Copays Act, support passage. -Support coverage of and access to all epilepsy treatments including through preservation of Medicare Part Ds Six Protected Classes policy -Reauthorization of the Advance Premium Tax Credits -Support patient-centric implementation of Medicare Part D out-of-pocket cap and the Medicare Prescription Payment Plan -Urge patient priorities like standardized health plans, network adequacy, and keeping insurance brokers accountable in the ACA marketplace exchanges. -Ensure continued access to needed healthcare via telehealth including at the VA and prescribing of epilepsy medications that are controlled substances -Requests to join the Congressional Epilepsy Caucus. -S. 1024/H.R. 2151, Seizure Awareness and Preparedness Act, support passage -Support protecting the current structure of the National Institutes of Health, including opposing changes to the Facilities & Administrative Cost Reimbursements -Support legislation and regulations to reduce the burden of medical debt -S. Con. Res. 7/H. Con. Res. 14, Oppose any cuts to Medicaid -Express concern with HHS Reductions in Force related to epilepsy -Oppose changes to the regulatory process and limits on opportunities for public comment -Support PBM reform, including the Safe Step Act -Support programs that assist caregivers Civil Rights/Civil Liberties: -Support implementation of disability provisions in FAA reauthorization Education: -Oppose changes to the Department of Education that could impede the rights of students with disabilities

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) Veterans Affairs, Dept of (VA) Federal Aviation Administration (FAA) Transportation, Dept of (DOT) Education, Dept of

Reported filing-period amount: $160,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION OF AMERICA

Registrant: CROSSROADS STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30)
Jul 18, 2026

Reported lobbying issue

Health Issues: Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform. Taxation/Internal Revenue Code: Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION OF AMERICA

Registrant: CROSSROADS STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Support coverage of and access to all epilepsy treatments. Support PBM reform. Taxation/Internal Revenue Code: Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EPILEPSY FOUNDATION OF AMERICA

Registrant: CROSSROADS STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Health Issues: Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act. Support coverage of and access to all epilepsy treatments. Support PBM reform. Taxation/Internal Revenue Code: Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗
Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.